The big announcement is the one released by GSK regarding production. It seems they have demand to justify more than 50-60m doses per annum.
The presentation does provide some useful information i.e. LANI works on the tamiflu resistant seasonal strains. It will be interesting to see if DS/BTA test LANI on the swine flu.
Just a matter of weeks now before we see developments on several fronts. I'll be holding through them all. Traders will have many opportunities as well due to the news flow set to come. My target is well above current prices, if it wasn't I would probably be trading the stock as well. My fear trading is that a LANI deal could be signed at any time and the gap could be massive... hence the hold.
Good luck.
new investor presentation on biota website, page-3
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)